0001668397-24-000049.txt : 20240306 0001668397-24-000049.hdr.sgml : 20240306 20240306163657 ACCESSION NUMBER: 0001668397-24-000049 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240304 FILED AS OF DATE: 20240306 DATE AS OF CHANGE: 20240306 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Troendle August J. CENTRAL INDEX KEY: 0001622058 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37856 FILM NUMBER: 24726478 MAIL ADDRESS: STREET 1: 5375 MEDPACE WAY CITY: CINCINNATI STATE: OH ZIP: 45227 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Medpace Holdings, Inc. CENTRAL INDEX KEY: 0001668397 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 320434904 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5375 MEDPACE WAY CITY: CINCINNATI STATE: OH ZIP: 45227 BUSINESS PHONE: (513) 579-9911 MAIL ADDRESS: STREET 1: 5375 MEDPACE WAY CITY: CINCINNATI STATE: OH ZIP: 45227 4 1 wk-form4_1709760994.xml FORM 4 X0508 4 2024-03-04 0 0001668397 Medpace Holdings, Inc. MEDP 0001622058 Troendle August J. C/O MEDPACE HOLDINGS, INC. 5375 MEDPACE WAY CINCINNATI OH 45227 1 1 1 0 CEO 0 Common Stock 2024-03-04 4 S 0 50000 403.12 D 4983019 I By Medpace Investors, LLC Common Stock 2024-03-05 4 S 0 50000 402.70 D 4933019 I By Medpace Investors, LLC Common Stock 806643 D The transactions reported on this Form 4 were effected pursuant to a limit order placed by Medpace Investors, LLC ("MPI") during an open window period. The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $400.52 to $408.21. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $400.00 to $404.39. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. /s/ Stephen P. Ewald, Attorney-in-Fact for August J. Troendle 2024-03-06